Head and Neck Cancer Survivors Have Increased Suicide Risk

Head and Neck Cancer Survivors Have Increased Suicide Risk

Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.

Affordable Care Act Has Positive Impact on Outcomes Among Those With Head and Neck Cancer

Affordable Care Act Has Positive Impact on Outcomes Among Those With Head and Neck Cancer

A prospective study collected data on the impact of the ACA on percent insured and outcomes for patients with HNSCC in the first years of healthcare law.

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer

Results of a population-based survey, presented at the 2018 ASCO Quality Care Symposium, revealed patients' perceptions regarding choice of treatment of differentiated thyroid cancer (DTC).

SCOOPs Program Improves Patient Experience, Reduces Costs

SCOOPs Program Improves Patient Experience, Reduces Costs

Researchers report on the effectiveness results of the Supportive Care of Oncology Patients (SCOOPs) Program were presented at the 2018 ASCO Quality Care Symposium.

Integrating Preoperative Oral Care Into Cancer Treatment Plans

Integrating Preoperative Oral Care Into Cancer Treatment Plans

Oral care by a dentist was found to reduce pathogenic bacterial plaque thereby decreasing the risk of postoperative pneumonia, a potentially fatal adverse effect, in patients undergoing surgical procedures for cancer.

Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors

Late Lower Cranial Neuropathy Worsens Symptom Burden in Oropharyngeal Cancer Survivors

Researchers conducted a cross-sectional study to determine the incidence and effect of late lower cranial neuropathies on survivors of oropharyngeal cancers.

Updates on the Clinical Diagnosis and Management of Ocular Sebaceous Carcinoma: a Brief Review of the Literature

Updates on the Clinical Diagnosis and Management of Ocular Sebaceous Carcinoma: a Brief Review of the Literature

[OncoTargets and Therapy] Disease specifics, demographics, clinical presentation, and pathology, plus diagnosis and management of ocular SC are highlighted and discussed, including recent advances in management of this aggressive malignancy.

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

Malnutrition, Decreased QOL Possible After Radiation Therapy for Head and Neck Cancer

In a retrospective study, researchers used established tools to measure the nutritional status of patients with head and neck cancer before, immediately after, and at 2 follow-up points after radiotherapy.

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator

The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

A review of current options and ongoing trials for managing ARIE, a common esophageal adverse effect caused by radiotherapy to the thoracic region for lung, breast, or head and neck cancers, or lymphoma.

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

Head and Neck Cancer Survival Improved When irAEs Occur During Anti-PD-1 Therapy

Researchers evaluated whether the development of irAEsc among patients with metastatic head and neck cancer who have failed platinum-based chemotherapy could improve patient outcomes.

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Ado-trastuzumab Emtansine Effective in HER2 Amplified Non-breast, Non-gastric Cancers

Study results presented at 2018 ASCO Annual Meeting demonstrated effectiveness of ado-trastuzumab emtansine in non-breast non-gastric HER2-amplified cancers.

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes

A study presented at the 2018 ONS Annual Congress explored whether patients can safely bypass SICU after HNC surgery, transferring directly from PACU to a specialized unit within the SO.

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

Posttreatment Visual Function, Ocular Symptoms Impact QOL in Head and Neck Cancer

A link between visual function, ocular symptoms, and quality of life was found in cross-sectional study of patients who underwent radiotherapy for head and neck cancers, according to a presentation at the 2018 ONS Annual Congress.

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer

FDA grants approval to immunotherapy combination in the treatment of unresectable and metastatic BRAF V600E mutation-positive anaplastic thyroid cancer (ATC).

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

Long-term Impact of Retinoblastoma Therapy on Vision-Related Quality of Life

Using the NEI-VFQ-25, researchers assessed vision-targeted health-related quality of life for survivors of retinoblastoma.

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Incidence, Age at Diagnosis Increasing in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

A retrospective study demonstrates an increase in HPV16-positive status among patients with OPSCC and a corresponding increase in age at diagnosis.

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

Chronic Opioid Use Observed in More Than 50% of Oropharynx Cancer Cases

Results of a retrospective review assessing the prevalence of chronic opioid use among patients with oropharynx cancer after surgery was presented at the 2018 American Head & Neck Society Annual Meeting.

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

HMB/Arg/Gln Does Not Reduce Oral Mucositis Incidence in Head and Neck Cancer

In a phase 2 study, researchers sought to determine the effectiveness of adding HMB/Arg/Gln to cisplatin-based chemoradiotherapy for patients with head and cancers to prevent CRT-induced oral mucositis.

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids

Researchers compared opioid use between head and neck cancer (HNCA) and lung or colon cancer (LCCA) cohorts.

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

Outcomes in SCCHN Improved With Swap of Docetaxel for 5-FU in Palliative Regimen

Study results show the effect on high-grade toxicity when 5-FU is replaced with docetaxel in the EXTREME regimen in the palliative treatment of patients with metastatic SCCHN.

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

Preoperative Aspirin Use May Not Increase Risk of Bleeding in Thyroid Surgery

This study sought to determine if continuing preoperative aspirin therapy would increase the risk of bleeding complications in patients undergoing thyroid surgery.

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

Study compared the effect of treatments on quality of life in treatment-naïve patients with HNC vs those who underwent radiotherapy and/or chemotherapy, and compared with cancer-free patients.

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

[Cancer Management and Research] Radiation dose, fractionation strategies, and predictive factors of response to therapy in patients with esophageal carcinoma are reviewed to determine if more intense local therapy would lead to better outcomes and for which patients.

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

In this study, researchers sought to determine the effect depressive symptoms during treatment planning had on immediate and long-term outcomes for patients with head and neck cancer.

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Papillary thyroid cancer patients with LND 0.19 have worse disease-specific, overall survival, researchers found.

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Periodontal pathogen Tannerella forsythia linked to increased risk of esophageal adenocarcinoma

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

Using the statewide Utah Population Database, investigators sought to determine the long-term effects of thyroid cancer on survivors who were younger than 40 years at diagnosis.

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

Data on psychosocial and psychiatric variables of patients with HNC prior to treatment was analyzed to determine the extent of cognitive impairment and quality of life for patients with head and neck cancer, and its impact on patient outcomes.

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

Negative Margins, Lymph Node Yields Predict Survival

Negative Margins, Lymph Node Yields Predict Survival

Patients with head and neck cancer treated at hospitals attaining the combined metric of a 90 percent or higher negative margin rate and 80% percent of cases achieving a LNY of 18 or more experienced a significant reduction in mortality.

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

Aggressive de-escalation of chemoradiation after surgery in patients with HPV-associated OPSCC led to similar disease control and improved quality of life and safety profile compared with historical controls, according to data presented at the ASTRO 59th Annual Meeting.

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

A quality improvement project demonstrates that routine distress assessment using the NCCN DT/PL in patients with head and neck cancers improves referrals for psychosocial services.

Most Skull Radiation Patients Show No Cognitive Impairment

Most Skull Radiation Patients Show No Cognitive Impairment

The researchers found that the majority of patients had no frank detectable cognitive impairment after undergoing skull base irradiation.

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

Intervention with resistance training and nutritional supplements during and after radiation therapy is not only feasible, but also shown to prevent loss of muscle mass and improve quality of life in patients with head and neck cancer (HNC).

Risk of Thyroid Cancer Increased With Fruit Juice Consumption, No Effect With Fruit and Vegetable Consumption

Risk of Thyroid Cancer Increased With Fruit Juice Consumption, No Effect With Fruit and Vegetable Consumption

No correlation was found between fruit and vegetable consumption and the risk of differentiated thyroid cancer, but a positive trend may be associated with fruit juice intake.

Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients

Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients

Results from a sub-analysis of the impact of age on the safety and efficacy of lenvatinib in patients with RR-DTC in the SELECT trial showed that lenvatinib significantly increased PFS.

Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma

Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma

Immunotherapy regimens FDA-approved for the treatment of melanoma may also be an option for a rare and aggressive form of papillary thyroid cancer.

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.

Adjuvant + Neoadjuvant Pembrolizumab Safe in Patients Undergoing HNSCC Surgery

Adjuvant + Neoadjuvant Pembrolizumab Safe in Patients Undergoing HNSCC Surgery

Study also provides evidence supporting an anti-tumor effect associated with a single preoperative dose of pembrolizumab.

ESW Technique Improves Nanoparticle Drug Delivery to Solid Tumors with Restricted Blood Flow

ESW Technique Improves Nanoparticle Drug Delivery to Solid Tumors with Restricted Blood Flow

Combining extracorporeal shock wave (ESW) technique with nanoparticle delivery improves treatment of difficult-to-treat solid tumors, such as anaplastic thyroid cancer.

The United States Services Task Force (USPSTF) Recommends Against Thyroid Cancer Screening

The United States Services Task Force (USPSTF) Recommends Against Thyroid Cancer Screening

Although screening is often recommended as the first line of prevention for most cancers, recent recommendation from the USPSTF advises against thyroid cancer screening in nonsymptomatic adults.

Survivorship Care Plans Specific to Head and Neck Cancers Enable Transition to Posttreatment Care

Survivorship Care Plans Specific to Head and Neck Cancers Enable Transition to Posttreatment Care

Disease-specific survivorship care plans (SCPs) for head and neck cancer support a successful transition to a healthy lifestyle after curative intent therapy of larynx and oral cavity/pharynx cancer.

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

A literature review noted improvements in quality of life after patients were coached and educated following radiotherapy for HPV-associated oropharyngeal cancers.

ASTRO Guideline Addresses Curative Treatment of Oropharyngeal Cancer

ASTRO Guideline Addresses Curative Treatment of Oropharyngeal Cancer

Clinical practice guideline from ASTRO addresses optimal radiation doses and fractionation schedules, integrating therapies, and induction chemotherapy for oropharyngeal squamous cell carcinoma (OPSCC).

Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer

Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer

Thyroid is more likely to be managed with surgical intervention when patients have access to expanded health insurance.

Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations

Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations

A report on incidence of thyroid cancer shows incidence of the disease is increasing among certain populations: younger persons, Hispanic, and African American.

Continuing Nivolumab After Progression of Head and Neck Cancer May Improve Survival

Continuing Nivolumab After Progression of Head and Neck Cancer May Improve Survival

Continuing immunotherapy after disease progression extends survival for some patients with head and neck cancer.

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

Protein produced by chronically infected cells in persons with HPV16 infection serves as a biomarker for risk of cancer of the oropharynx.

Thymomas Trigger Newly Described Autoimmune Endocrine Disease

Thymomas Trigger Newly Described Autoimmune Endocrine Disease

Thymomas can result in a newly described autoimmune disease, potentially leading to hypopituitarism,

No Intervention for Small Thyroid Cancers May Cause Anxiety

No Intervention for Small Thyroid Cancers May Cause Anxiety

Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.

HPV Vaccination Discussions Need to Focus on Education, Awareness

HPV Vaccination Discussions Need to Focus on Education, Awareness

The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.

ASCO Endorses ACS Head and Neck Survivorship Care Guideline

ASCO Endorses ACS Head and Neck Survivorship Care Guideline

ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.

Nurse Navigators Improve Physician Engagement in Pretreatment Discussions

Nurse Navigators Improve Physician Engagement in Pretreatment Discussions

Oncology nurse navigators improved physician engagement in multidisciplinary discussions prior to the initiation of treatment for patients with head and neck cancer.

Single Chemotherapy Dose Informs Treatment Strategy for Advanced Laryngeal Cancer

Single Chemotherapy Dose Informs Treatment Strategy for Advanced Laryngeal Cancer

A new approach in which patients receive a single dose of chemotherapy may greatly improve the laryngeal cancer survival rate.

HNSCC Survival Worse for Patients in Lower Socioeconomic Population

HNSCC Survival Worse for Patients in Lower Socioeconomic Population

Investigators determined the impact of socioeconomic status on disease status at presentation and survival among patients with head and neck squamous cell carcinoma.

Oral SCC Diagnosis Has Greater Affect on Sexual Behavior Than HPV Status

Oral SCC Diagnosis Has Greater Affect on Sexual Behavior Than HPV Status

The impact of oral squamous cell carcinoma (OSCC) diagnosis and treatment on sexual behavior and relationship stress with respect to HPV status was evaluated in this study. Participants included patients with HPV-positive and HPV-negative disease, as well as partners.

Bioselection-individualized Treatment Modality Selection Improves Advanced Laryngeal Cancer Survival

Bioselection-individualized Treatment Modality Selection Improves Advanced Laryngeal Cancer Survival

Multivariate analysis indicates that disease-specific survival of individuals with advanced laryngeal cancer was improved for those receiving neoadjuvant therapy.

High CVD Risk in Patients With Head, Neck Squamous Cell Cancer

High CVD Risk in Patients With Head, Neck Squamous Cell Cancer

Twenty-three percent of patients with HNSCC had CVD at the time of their diagnosis.

Cancer Stem Cell Research Suggests a New Approach to Treatment Resistance in Esophageal Cancer

Cancer Stem Cell Research Suggests a New Approach to Treatment Resistance in Esophageal Cancer

Researchers reveal that miR-17 appears to be important in driving esophageal tumor resistance to radiotherapy.

Cancer Cachexia Associated With Poor Outcomes

Cancer Cachexia Associated With Poor Outcomes

Findings at 6 and 12 months after treatment for advanced head and neck cancer indicate a higher risk of recurrences for those reporting cachexia after their treatment.

Uric Acid May Mark Progression for Nasopharyngeal Cancer

Uric Acid May Mark Progression for Nasopharyngeal Cancer

High pretreatment uric acid may be a clinical biomarker for lung metastasis.

Stepped Psychological Care for Patients with Head and Neck or Lung Cancer

Stepped Psychological Care for Patients with Head and Neck or Lung Cancer

For patients with head and neck or lung cancer, stepped care programs may offer a more affordable yet effective approach.

Panitumumab Plus Accelerated RT Not Effective for Locoregionally Advanced HNSCC

Panitumumab Plus Accelerated RT Not Effective for Locoregionally Advanced HNSCC

Progression-free survival with panitumumab plus accelerated-fractionation radiotherapy was compared with that of cisplatin plus standard-fractionation radiotherapy in patients with locoregionally advanced HNSCC in a recently published study.

USPSTF Continues Recommendations Against Thyroid Cancer Screening

USPSTF Continues Recommendations Against Thyroid Cancer Screening

Widespread routine thyroid cancer screening can lead to overdiagnosis and overtreatment, the USPSTF contends.

Metabolic Syndrome Associated With Increased Risk of Esophageal Cancer in Older Patients

Metabolic Syndrome Associated With Increased Risk of Esophageal Cancer in Older Patients

A retrospective evaluation investigated the association between risk of esophageal cancer, metabolic syndrome, Barrett esophagus, and GERD in older persons.

Smoking-related Cancer Deaths Highest in Southern United States

Smoking-related Cancer Deaths Highest in Southern United States

Smoking-attributable cancer mortality estimates have not been established by state; therefore, in this study, the proportion of cancer deaths among persons 35 years and older related to cigarette smoking in 2014 was calculated for each state and DC.

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

Outcomes Are Better for HPV16-Associated Oropharyngeal Cancer, but Not for Other HPV Strains

Patients with oropharyngeal tumors that harbor HPV16 have higher 5-year survival and lower recurrence rates than patients with tumors that harbor other HPV strains or are HPV-negative.

Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC

Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC

Patients with head and neck cancer treated with IMRT had a significantly shorter duration of feeding tube placement compared with those who received 3DRT.

Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer

Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer

Transoral robotic surgery (TORS) with or without radiation therapy or chemotherapy is an effective treatment option for patients with oropharyngeal cancer regardless of their p16 status.

Outcomes in Patients With Brain Metastasis from Esophageal Carcinoma

Outcomes in Patients With Brain Metastasis from Esophageal Carcinoma

[Journal of Gastrointestinal Oncology] This research examines factors associated with survival in patients with brain metastasis from esophageal cancer.

Poor Oral Health Associated With OPSCC Regardless of HPV Status

Poor Oral Health Associated With OPSCC Regardless of HPV Status

Despite a higher risk for HPV-negative orophayngeal squamous cell carcinoma (OPSCC), poor oral health appears to be associated with OPSCC regardless of HPV status.

Gemcitabine Plus Cisplatin Prolongs PFS in Nasopharyngeal Cancer

Gemcitabine Plus Cisplatin Prolongs PFS in Nasopharyngeal Cancer

Gemcitabine in combination with cisplatin is associated with a significant improvement in progression-free survival in nasopharyngeal carcinoma.

Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinoma

Quality of Life and Cosmetic Result of Single-port Access Endoscopic Thyroidectomy via Axillary Approach in Patients with papillary thyroid carcinoma

[OncoTargets and Therapy] This research reviews the effects of single-port access transaxillary totally endoscopic thyroidectomy on outcomes following surgery, including quality of life and cosmetic result, in patients with papillary thyroid carcinoma (PTC).

Cabozantinib May Be More Effective in Patients With Certain Mutations

Patients with medullary thyroid cancer who harbor RET M918T or RAS mutations may derive greater clinical benefit from cabozantinib compared with patients who do not have those genetic mutations.

Study Evaluates Systemic Therapy Use With RT Among Older Patients With Head and Neck Cancer

In contrast of available prospective data, most older patients with locoregionally advanced head and neck cancer are treated with definitive radiotherapy also receive systemic therapy.

Chemoradiation Combination Could Preserve Larynx in Patients With Laryngeal and Hypolaryngeal Cancer

Chemoradiation Combination Could Preserve Larynx in Patients With Laryngeal and Hypolaryngeal Cancer

Researchers assessed the rates of laryngeal preservation and laryngectomy-free survival in patients with laryngeal or hypopharyngeal cancer who received the monoclonal antibody cetuximab and radiation therapy or radiation therapy alone.

Methadone May Be Superior to Fentanyl for Neuropathic Pain

Methadone May Be Superior to Fentanyl for Neuropathic Pain

Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

Medicaid Insurance Linked to Worse Head and Neck Cancer Outcomes

A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.

Transforming the Care of Patients With Thyroid Cancer

Transforming the Care of Patients With Thyroid Cancer

There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.

Incidence of Oropharyngeal Cancer Increasing Among Older Patients

Incidence of Oropharyngeal Cancer Increasing Among Older Patients

The incidence of oropharyngeal squamous cell carcinoma is increasing among older patients residing in the United States, likely due to the increase in HPV-associated malignancies.

Broccoli Sprout Extracts May Prevent Recurrence of Some Oral Cancers

Broccoli Sprout Extracts May Prevent Recurrence of Some Oral Cancers

Beverages derived from broccoli sprout extracts were found to have preclinical chemopreventive activity against oral cancer induced by carcinogens.

Investigation of a Novel Method for Managing Oral Cancer Pain Is Awarded NIDCR Grant

Investigation of a Novel Method for Managing Oral Cancer Pain Is Awarded NIDCR Grant

Quality of life for patients with oral cancer can be dismal due to cancer-related pain. An NIDCR grant is supporting the investigation of a nonviral gene delivery method for treating oral cancer pain safely and effectively.

New Nanoplatform Improves Drug Delivery in Anaplastic Thyroid Cancer

Scientists developed an innovative nanoplatform to more effectively deliver RNA interference to anaplastic thyroid cancer (ATC) sites. ATC is the most aggressive form of thyroid cancer; mortality is almost 100% and median survival is 3 to 5 months.

Stepped Care Effective for Psychological Distress

Stepped Care Effective for Psychological Distress

Stepped care is effective and reduces recovery time among patients with head and neck cancer or lung cancer and untreated psychological distress.

Nimotuzumab + Radiotherapy Less Toxic Than Cisplatin + Radiotherapy for Stage III/IVB Nasopharyngeal Cancer

Nimotuzumab + Radiotherapy Less Toxic Than Cisplatin + Radiotherapy for Stage III/IVB Nasopharyngeal Cancer

Patients with locally advanced nasopharyngeal cancer concurrently treated with nimotuzumab and radiotherapy had similar rates of progression-free and overall survival to those treated with cisplatin and radiotherapy, but with significantly fewer GI and hematologic toxicities, according to phase 3 trial results presented at the ASCO 2016 Annual Meeting.

Cisplatin, Cetuximab Show Similar Locoregional Control in Unresectable Head and Neck Cancer

Cisplatin, Cetuximab Show Similar Locoregional Control in Unresectable Head and Neck Cancer

Survival results from the first randomized phase 3 trial to compare cisplatin-radiotherapy with cetuximab-radiotherapy after induction chemotherapy in patients with locally advanced unresectable head and neck cancer remain inconclusive, with both arms showing good locoregional control, greater than 50% at 3 years, attendees at the ASCO 2016 Annual Meeting were told.

Concurrent Chemoradiotherapy Remains Standard of Care in Locally Advanced SCCHN

Concurrent Chemoradiotherapy Remains Standard of Care in Locally Advanced SCCHN

A phase 3 noninferiority study has found that in patients with nonoperable locally advanced squamous cell cancer of the head and neck, concurrent chemoradiotherapy remains the standard treatment, according to results presented at the ASCO 2016 Annual Meeting.

Survival in Head and Neck Cancer Increased With Nivolumab Over Chemotherapy

The immunotherapy drug nivolumab conferred a survival benefit in patients with head and neck cancer over standard chemotherapy.

MASCC Tool Improves Documentation of Dermatologic Toxicities of TKIs

MASCC Tool Improves Documentation of Dermatologic Toxicities of TKIs

Incorporating a modified MASCC grading tool for evaluating epidermal growth factor receptor inhibitor (EGFRI) toxicities and quality of life improved the rate of skin assessments and documentation.

Oncology Nurse-led Team Can Reduce Treatment Delays, Hospitalizations for Patients With Head and Neck Cancer

Oncology Nurse-led Team Can Reduce Treatment Delays, Hospitalizations for Patients With Head and Neck Cancer

An oncology nurse-led team approach can reduce treatment delays and hospitalizations and improve quality of care for patients with head and neck cancer.

Targeted Therapy Enhances Chemotherapy, Improves Outcomes in Retinoblastoma

The effectiveness of chemotherapy was enhanced by targeting survivin, a protein that inhibits apoptosis or cell death, according to preclinical research in cells and mouse models of retinoblastoma.

30-day Readmission After Parotid Cancer Surgery Linked to Increased 30-day Mortality Risk

Having an unplanned readmission within 30 days of undergoing definitive surgery is associated with increased risk of 30-day mortality among patients with previously untreated parotid cancer.

Radioactive Iodine Treatment Affects Fertility in Women With Thyroid Cancer

In women of reproductive age who have thyroid cancer, their remaining egg supply is affected by radioactive iodine treatment, potentially reducing their fertility.

Older Age Patients with HNSCC Benefit from Afatinib vs Methotrexate

Older Age Patients with HNSCC Benefit from Afatinib vs Methotrexate

Patients age 65 years or older with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) did not have worse clinical outcomes.

Persistent Head and Neck Cancer Cells Tracked Down by Imaging Scans

Persistent Head and Neck Cancer Cells Tracked Down by Imaging Scans

Posttreatment image-guided surveillance achieved similar survival rates as planned neck dissection in patients with head and neck.

ACS Guideline Provides Recommendations for Care of Head and Neck Cancer Survivors

ACS Guideline Provides Recommendations for Care of Head and Neck Cancer Survivors

A new guideline from the American Cancer Society provides recommendations on follow-up care for survivors of head and neck cancer.

Image-Guided Surveillance Beneficial for Head and Neck Cancer

Image-Guided Surveillance Beneficial for Head and Neck Cancer

Similar survival seen for PET-CT-guided surveillance and planned neck dissection, but fewer operations.

Wellness Programs Needed for Head and Neck Cancer Caregivers

Wellness Programs Needed for Head and Neck Cancer Caregivers

Wellness programs offering a variety of supportive tools are needed for caregivers of patients with head and neck cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs